Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC475

Lútesín (177Lu) vipivótíðtetraxetan

  • Status:
    Veitt
  • Application date:
    11.7.2024
  • Application published:
    15.8.2024
  • Grant published:
    15.12.2025
  • Max expiry date:
    8.12.2037
  • Medicine name:
    Pluvicto
  • Medicine for children:
    No

Timeline

Today
11.7.2024Application
15.8.2024Publication
15.12.2025Registration
8.12.2037Expires

Marketing license

  • IS authorization number:
    EU/1/22/1703
  • Date:
    3.1.2023
  • Foreign authorization number:
    EU/1/22/1703
  • Date:
    9.12.2022

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056 Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents